Neutropenic sepsis is a life-threatening condition with mortality rates reported to range
between 2 and 21% in adults. It can occur following chemotherapy treatment, due to disease …

Neutropenic sepsis remains a time critical and potentially fatal complication of systemic anti-
cancer therapy. A target 'door to needle'time of one hour for first dose empirical intravenous …

Neutropenic sepsis is a potentially life-threatening complication of chemotherapy and has
an associated mortality of 2% to 21%. Patients can deteriorate rapidly and are usually …

Neutropenic Sepsis (NS) is a well recognised treatment complication, typically occurring 7-
10 days following cancer cytotoxic chemotherapy. Colleagues in acute medicine will be only …

Recent disquiet at inadequacies in the immediate management of neutropenic sepsis in the
UK led to a new, gold standard 'door‐to‐needle'time of 1 h for the administration of …

Purpose Many aspects of the management of neutropenic sepsis remain controversial.
These include the choice of empiric antibiotic, the duration of antibiotic therapy and the …

Background: Neutropenic sepsis is a potentially fatal complication of cytotoxic chemotherapy
requiring rapid, specialist input. The NICE Clinical Guideline 151 1 advises door to needle …

Neutropenic sepsis can be life threatening, with mortality 2-21%. The heterogeneity of
patients referred with “suspected neutropenic sepsis” has led to strategies being developed …

Objectives Patients with suspected Neutropenic sepsis require rapid antibiotic
administration, but despite extensive education, only 67% of patients received antibiotics …

Background Neutropenic sepsis (NS) is a common and predictable complication of bone
marrow disorders and cytotoxic chemotherapy, with an estimated incidence of 70–100 …